| Osf Hospice 2265 West Altorfer Drive, Peoria, IL, 61615 | |
| (309) 683-7703 |
News Archive
Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE™ (beclomethasone dipropionate [BDP]) HFA, its nasal aerosol corticosteroid in development for the treatment of perennial allergic rhinitis (PAR) and seasonal allergic rhinitis (SAR).
As part of the commitment to providing turn-key innovative solutions for the automotive industry, Bruker's Nano Surfaces Division today announced the release of the Brake Material Screening Module. The module expands the capabilities of the UMT TriboLab, the most widely used platform worldwide for testing friction and wear.
Marianne Gausche-Hill, M.D., and Kate Remick, M.D. - lead investigators at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) - are spearheading a statewide, web-based survey scheduled to roll out Jan. 6, 2012 that will help assess the pediatric emergency readiness of hospital emergency departments.
Assembled in Tel Aviv for the first event held in Israel under the EUREKA Chairmanship year, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in a variety of areas, including renewable energy and advanced environmental technologies, in accordance with EUREKA's strategic targets defined for the 2010-2011 Championship year.
New findings in breast cancer research by an international team of scientists contradict the prevailing belief that only basal-like cells with stem cell qualities can form invasive tumors. Research led by Ole William Petersen at the University of Copenhagen (CU) and Mina Bissell of the Lawrence Berkeley National Laboratory (Berkeley Lab) and has shown that luminal-like cells with no detectable stem cell qualities can generate larger tumors than their basal-like counterparts.
› Verified 5 days ago
| Name | Osf Hospice |
|---|---|
| Location | 2265 West Altorfer Drive, Peoria, Illinois |
| Hospice ID | 141546 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| SSA county code | 800 |
News Archive
Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE™ (beclomethasone dipropionate [BDP]) HFA, its nasal aerosol corticosteroid in development for the treatment of perennial allergic rhinitis (PAR) and seasonal allergic rhinitis (SAR).
As part of the commitment to providing turn-key innovative solutions for the automotive industry, Bruker's Nano Surfaces Division today announced the release of the Brake Material Screening Module. The module expands the capabilities of the UMT TriboLab, the most widely used platform worldwide for testing friction and wear.
Marianne Gausche-Hill, M.D., and Kate Remick, M.D. - lead investigators at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) - are spearheading a statewide, web-based survey scheduled to roll out Jan. 6, 2012 that will help assess the pediatric emergency readiness of hospital emergency departments.
Assembled in Tel Aviv for the first event held in Israel under the EUREKA Chairmanship year, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in a variety of areas, including renewable energy and advanced environmental technologies, in accordance with EUREKA's strategic targets defined for the 2010-2011 Championship year.
New findings in breast cancer research by an international team of scientists contradict the prevailing belief that only basal-like cells with stem cell qualities can form invasive tumors. Research led by Ole William Petersen at the University of Copenhagen (CU) and Mina Bissell of the Lawrence Berkeley National Laboratory (Berkeley Lab) and has shown that luminal-like cells with no detectable stem cell qualities can generate larger tumors than their basal-like counterparts.
› Verified 5 days ago
| NPI Number | 1023049574 |
| Organization Name | Saint Francis Medical Center |
| Address | 2265 W Altorfer Dr Peoria, Illinois, 61615 |
| Phone Number | (309)683-7745 |
News Archive
Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE™ (beclomethasone dipropionate [BDP]) HFA, its nasal aerosol corticosteroid in development for the treatment of perennial allergic rhinitis (PAR) and seasonal allergic rhinitis (SAR).
As part of the commitment to providing turn-key innovative solutions for the automotive industry, Bruker's Nano Surfaces Division today announced the release of the Brake Material Screening Module. The module expands the capabilities of the UMT TriboLab, the most widely used platform worldwide for testing friction and wear.
Marianne Gausche-Hill, M.D., and Kate Remick, M.D. - lead investigators at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) - are spearheading a statewide, web-based survey scheduled to roll out Jan. 6, 2012 that will help assess the pediatric emergency readiness of hospital emergency departments.
Assembled in Tel Aviv for the first event held in Israel under the EUREKA Chairmanship year, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in a variety of areas, including renewable energy and advanced environmental technologies, in accordance with EUREKA's strategic targets defined for the 2010-2011 Championship year.
New findings in breast cancer research by an international team of scientists contradict the prevailing belief that only basal-like cells with stem cell qualities can form invasive tumors. Research led by Ole William Petersen at the University of Copenhagen (CU) and Mina Bissell of the Lawrence Berkeley National Laboratory (Berkeley Lab) and has shown that luminal-like cells with no detectable stem cell qualities can generate larger tumors than their basal-like counterparts.
› Verified 5 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.9 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 100.0 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 80.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.4 | 97.3 |
| Patients who got timely treatment for shortness of breath | 98.3 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE™ (beclomethasone dipropionate [BDP]) HFA, its nasal aerosol corticosteroid in development for the treatment of perennial allergic rhinitis (PAR) and seasonal allergic rhinitis (SAR).
As part of the commitment to providing turn-key innovative solutions for the automotive industry, Bruker's Nano Surfaces Division today announced the release of the Brake Material Screening Module. The module expands the capabilities of the UMT TriboLab, the most widely used platform worldwide for testing friction and wear.
Marianne Gausche-Hill, M.D., and Kate Remick, M.D. - lead investigators at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) - are spearheading a statewide, web-based survey scheduled to roll out Jan. 6, 2012 that will help assess the pediatric emergency readiness of hospital emergency departments.
Assembled in Tel Aviv for the first event held in Israel under the EUREKA Chairmanship year, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in a variety of areas, including renewable energy and advanced environmental technologies, in accordance with EUREKA's strategic targets defined for the 2010-2011 Championship year.
New findings in breast cancer research by an international team of scientists contradict the prevailing belief that only basal-like cells with stem cell qualities can form invasive tumors. Research led by Ole William Petersen at the University of Copenhagen (CU) and Mina Bissell of the Lawrence Berkeley National Laboratory (Berkeley Lab) and has shown that luminal-like cells with no detectable stem cell qualities can generate larger tumors than their basal-like counterparts.
› Verified 5 days ago
| Home Health Aides | 14 |
| Licensed Practical or Vocational Nurses | 3 |
| Medical Social Workers | 6 |
| Physicians | 5 |
| Registered Nurses | 34 |
| Other Personnel | 17 |
| Total Employees | 79 |
|---|
News Archive
Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE™ (beclomethasone dipropionate [BDP]) HFA, its nasal aerosol corticosteroid in development for the treatment of perennial allergic rhinitis (PAR) and seasonal allergic rhinitis (SAR).
As part of the commitment to providing turn-key innovative solutions for the automotive industry, Bruker's Nano Surfaces Division today announced the release of the Brake Material Screening Module. The module expands the capabilities of the UMT TriboLab, the most widely used platform worldwide for testing friction and wear.
Marianne Gausche-Hill, M.D., and Kate Remick, M.D. - lead investigators at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) - are spearheading a statewide, web-based survey scheduled to roll out Jan. 6, 2012 that will help assess the pediatric emergency readiness of hospital emergency departments.
Assembled in Tel Aviv for the first event held in Israel under the EUREKA Chairmanship year, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in a variety of areas, including renewable energy and advanced environmental technologies, in accordance with EUREKA's strategic targets defined for the 2010-2011 Championship year.
New findings in breast cancer research by an international team of scientists contradict the prevailing belief that only basal-like cells with stem cell qualities can form invasive tumors. Research led by Ole William Petersen at the University of Copenhagen (CU) and Mina Bissell of the Lawrence Berkeley National Laboratory (Berkeley Lab) and has shown that luminal-like cells with no detectable stem cell qualities can generate larger tumors than their basal-like counterparts.
› Verified 5 days ago
| Others | 1 |
| Total Volunteers | 1 |
|---|
News Archive
Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE™ (beclomethasone dipropionate [BDP]) HFA, its nasal aerosol corticosteroid in development for the treatment of perennial allergic rhinitis (PAR) and seasonal allergic rhinitis (SAR).
As part of the commitment to providing turn-key innovative solutions for the automotive industry, Bruker's Nano Surfaces Division today announced the release of the Brake Material Screening Module. The module expands the capabilities of the UMT TriboLab, the most widely used platform worldwide for testing friction and wear.
Marianne Gausche-Hill, M.D., and Kate Remick, M.D. - lead investigators at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) - are spearheading a statewide, web-based survey scheduled to roll out Jan. 6, 2012 that will help assess the pediatric emergency readiness of hospital emergency departments.
Assembled in Tel Aviv for the first event held in Israel under the EUREKA Chairmanship year, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in a variety of areas, including renewable energy and advanced environmental technologies, in accordance with EUREKA's strategic targets defined for the 2010-2011 Championship year.
New findings in breast cancer research by an international team of scientists contradict the prevailing belief that only basal-like cells with stem cell qualities can form invasive tumors. Research led by Ole William Petersen at the University of Copenhagen (CU) and Mina Bissell of the Lawrence Berkeley National Laboratory (Berkeley Lab) and has shown that luminal-like cells with no detectable stem cell qualities can generate larger tumors than their basal-like counterparts.
› Verified 5 days ago
| Unitypoint Hospice - Peoria Location: 120 Ne Glen Oak, Peoria, Illinois, 61636 Phone: (309) 683-7703 |
| Osf Hospice Location: 2265 West Altorfer Drive, Peoria, Illinois, 61615 Phone: (309) 683-7703 |